H3L Stock Overview
An investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
ClouDr Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.14 |
| 52 Week High | HK$0.69 |
| 52 Week Low | HK$0.12 |
| Beta | 0.37 |
| 11 Month Change | -8.33% |
| 3 Month Change | -0.69% |
| 1 Year Change | -81.78% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -92.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| H3L | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0.7% | 0.2% | 0.8% |
| 1Y | -81.8% | 13.9% | 8.6% |
Return vs Industry: H3L underperformed the German Healthcare industry which returned 17.4% over the past year.
Return vs Market: H3L underperformed the German Market which returned 9.1% over the past year.
Price Volatility
| H3L volatility | |
|---|---|
| H3L Average Weekly Movement | 19.3% |
| Healthcare Industry Average Movement | 4.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: H3L's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: H3L's weekly volatility has increased from 14% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 1,558 | Ming Kuang | www.cloudr.cn |
ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company’s integrated in-hospital solution offers chronic condition management solution to hospitals including hospital SaaS and proprietary artificial intelligence of things devices; and integrated out-of-hospital solution consists of pharmacy solution and individual chronic condition management solution. It also offers pharmacy solution, which includes pharmacy SaaS, pharmacy supplies, and sells stock keeping units based on its SaaS network in pharmacies; pharmacy SaaS that enables in-store, real-time online consultation, and prescription services; identifies pharmacy supplies sales opportunities based on the insights generated from prescription services; and retail and inventory management functions for pharmacies.
ClouDr Group Limited Fundamentals Summary
| H3L fundamental statistics | |
|---|---|
| Market cap | €88.55m |
| Earnings (TTM) | -€37.33m |
| Revenue (TTM) | €529.58m |
0.2x
P/S Ratio-2.4x
P/E RatioIs H3L overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| H3L income statement (TTM) | |
|---|---|
| Revenue | CN¥4.01b |
| Cost of Revenue | CN¥3.14b |
| Gross Profit | CN¥872.81m |
| Other Expenses | CN¥1.16b |
| Earnings | -CN¥282.90m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.48 |
| Gross Margin | 21.75% |
| Net Profit Margin | -7.05% |
| Debt/Equity Ratio | 33.3% |
How did H3L perform over the long term?
See historical performance and comparison